HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Connie L Erickson-Miller Selected Research

Thrombopoietin Receptors

1/2012Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.
1/2010Thrombopoietin receptor levels in tumor cell lines and primary tumors.
10/2009Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome.
9/2009Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.
2/2009Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
6/2007Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Connie L Erickson-Miller Research Topics

Disease

7Thrombocytopenia (Thrombopenia)
12/2013 - 06/2007
3Anoxia (Hypoxia)
06/2014 - 08/2010
2Carcinoma (Carcinomatosis)
01/2012 - 01/2010
2Neoplasms (Cancer)
01/2012 - 01/2010
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2010 - 10/2009
2Lymphoma (Lymphomas)
09/2010 - 01/2010
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2010 - 10/2009
1Inflammation
06/2014
1Hemorrhage
12/2013
1Sickle Cell Anemia (Hemoglobin S Disease)
12/2013
1Embolism (Embolus)
12/2013
1Breast Neoplasms (Breast Cancer)
01/2012
1Leukemia
09/2010
1Myocardial Infarction
08/2010
1Heart Failure
08/2010
1Infection
01/2010
1Hematologic Neoplasms (Hematological Malignancy)
01/2010
1Renal Cell Carcinoma (Grawitz Tumor)
01/2010
1Colonic Neoplasms (Colon Cancer)
01/2010
1Disease Progression
01/2010
1Chronic Hepatitis C
01/2010
1Sarcoma (Soft Tissue Sarcoma)
01/2010
1Anemia
12/2008

Drug/Important Bio-Agent (IBA)

6eltrombopagFDA Link
12/2013 - 06/2007
6Thrombopoietin ReceptorsIBA
01/2012 - 06/2007
2Transcription Factors (Transcription Factor)IBA
06/2014 - 08/2010
2Procollagen-Proline Dioxygenase (Prolyl Hydroxylase)IBA
06/2014 - 08/2010
2OxygenIBA
05/2012 - 08/2010
2Messenger RNA (mRNA)IBA
01/2012 - 01/2010
2Thrombopoietin (c-mpl Ligand)IBA
09/2010 - 01/2010
1GlobinsIBA
12/2013
1DioxygenasesIBA
05/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2010
1Stem Cell FactorIBA
12/2008
1GlucocorticoidsIBA
12/2008
1Tyrosine (L-Tyrosine)FDA Link
12/2008
1ErythropoietinFDA Link
12/2008
1Oncostatin MIBA
12/2008
1Phosphotransferases (Kinase)IBA
12/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2012 - 01/2010
1Catheters
12/2013
1Platelet Transfusion (Blood Platelet Transfusions)
12/2013
1Stem Cell Transplantation
12/2013
1Ligation
08/2010